Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Fármacos antipsicóticos de segunda generación para los trastornos de ansiedad

Información

DOI:
https://doi.org/10.1002/14651858.CD008120.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 diciembre 2010see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos mentales comunes

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Anna M Depping

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Katja Komossa

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Werner Kissling

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Stefan Leucht

    Correspondencia a: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

    [email protected]

Contributions of authors

Anna‐Mareike Depping: protocol development, searching, study selection, data extraction, report writing.

Stefan Leucht: protocol development, supervision of the review process and report writing.

Katja Komossa: protocol development, searching, study selection, data extraction.

Werner Kissling: protocol development.

Sources of support

Internal sources

  • Freistaat Bayern, Germany.

External sources

  • German Ministry of Education and Resarch (Bundesministerium für Bildung und Forschung, BMBF) grant number 01KG0818, Germany.

Declarations of interest

Anna Mareike Depping: none to declare.

Katja Komossa: none to declare.

Stefan Leucht: received speaker/consultancy/advisory board honoraria from SanofiAventis, BMS, EliLilly, GlaxoSmithKline, Janssen, Johnson and Johnson, Lundbeck and Pfizer. SanofiAventis and EliLilly supported research projects by Stefan Leucht.

Werner Kissling: received speaker or consultancy honoraria from SanofiAventis, BMS, Lilly, Janssen, Lundbeck, Bayer and Pfizer.

Acknowledgements

We would like to thank all members of the editorial team of the Cochrane Depression, Anxiety and Neurosis Review Group for their editorial assistance.

We would like to thank Dr. Schlosser from AstraZeneca for providing posters on quetiapine.

Version history

Published

Title

Stage

Authors

Version

2010 Dec 08

Second‐generation antipsychotics for anxiety disorders

Review

Anna M Depping, Katja Komossa, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD008120.pub2

2009 Oct 07

Second‐generation antipsychotic drugs for anxiety disorders

Protocol

Anna M Depping, Katja Komossa, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD008120

Differences between protocol and review

None.